Amyloid and amyloidosis

Journal of the American Academy of Dermatology

Volumn 18, Issue 1, 1988, Pages 1-16

  Breathnach, Stephen Michael ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOIDOSIS; HISTOLOGY; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SKIN AMYLOIDOSIS;

AMYLOID; AMYLOIDOSIS; COLCHICINE; HUMAN; PLASMA CELLS; SKIN DISEASES; SUPPORT, NON-U.S. GOV'T;

EID: 0023837830     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(88)70001-8     Document Type: Article

References (148)

1. Amyloid deposits and amyloidosis. The B-fibrilloses
2. High-resolution electron microscopic analysis of the amyloid fibril
3. X-ray diffraction studies on amyloid filaments
4. Infrared spectroscopy of human amyloid fibrils and immunoglobulin proteins
5. Amyloidosis: review of 236 cases
6. The cutaneous amyloidoses. II. Systemic forms
7. Secondary systemic amyloidosis: analysis of underlying disorders
8. Systemic amyloidosis complicating dermatoses
9. AA protein-related renal amyloidosis in drug addicts
10. Patterns of amyloidosis and their association with plasma cell dyscrasia, monoclonal immunoglobulins and Bence Jones proteins
11. The inherited systemic amyloidoses and localized amyloid deposits
12. Familial Mediterranean fever: a survey of 470 cases and a review of the literature
13. The Muckle-Wells' syndrome
14. Skin involvement in familial amyloidotic polyneuropathy
15. The cutaneous amyloidoses. I. Localized forms
16. Primary localized amyloidosis of the skin: clinical variants, histochemistry and ultrastructure
17. Guidelines for nomenclature
18. Studies on amyloid protein AP
19. Immunohistochemical demonstration of amyloid P component in skin of normal subjects and patients with cutaneous amyloidosis
20. Biology of serum amyloid P component
21. Amyloid P component is located on elastic fibre microfibrils in normal human tissue
22. The cutaneous amyloidoses. Pathogenesis and therapy
23. Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses
24. Structural identity of Bence-Jones and amyloid fibril proteins in a patient with plasma cell dyscrasia and amyloidosis
25. Creation of “amyloid” fibrils from Bence-Jones proteins in vitro
26. The major proteins of human and monkey amyloid substances: common properties including unusual N-terminal amino sequences
27. Amyloid protein SAA is associated with high density lipoprotein from normal serum
28. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy
29. Secondary localised cutaneous amyloidosis
30. Amyloid production by dermal fibroblasts. Electron microscopic studies on the origin of amyloid in various dermatoses and skin tumours
31. Localized amyloidosis in basal cell epitheliomas
32. Secondary localised cutaneous amyloidosis in melanocytic naevi
33. Colloid-amyloid bodies in PUVA-treated human psoriatic patients
34. Localised cutaneous amyloidosis: a clinical review of 100 cases including immunofluorescent studies
35. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I)
36. Amino acid sequences in amyloid proteins of k III immunoglobulin light-chain origin
37. Primary localised cutaneous amyloidosis: dermal amyloid deposits do not bind antibodies to amy loid A protein, prealbumin or fibronectin
38. Immunoglobulins and complement C3 in lichen amyloidosus: immunofluorescent study
39. Primary cutaneous amyloidosis: clinical, laboratorial and histopathological study of 25 cases: identification of gammaglobulins and C3 in the lesions by immunofluorescence
40. Myelomatosis following lichen amyloidosis
41. Macular amyloidosis: a study of 21 cases with special reference to the role of the epidermis in its histogenesis
42. The role of the epidermis in the histopathogenesis of lichen amyloidosus: histochemical correlations
43. Histogenesis of primary localized cutaneous amyloidosis: sequential change of epidermal keratinocytes to amyloid via filamen tous degeneration
44. Immunofluorescence studies on cutaneous amyloidosis with anti-keratin antibody
45. Amyloidogenesis in organlimited cutaneous amyloidosis: an antigenic identity between epidermal keratin and skin amyloid
46. Epidermal origin of the amyloid in localized cutaneous amyloidosis
47. Progress on cutaneous amyloidoses
48. Light and electron microscopic differentiation of amyloid and colloid or hyaline bodies
49. Primary systemic amyloidosis
50. Primary amyloidosis. A clinical and pathological study
51. Systematized amyloidosis. A review of the skin and mucous membrane lesions and a report of two cases
52. Primary systemic amyloidosis
53. Primary amyloidosis: a review
54. Primary systemic amyloidosis: a review and an experimental, genetic and clinical study of 29 cases with particular emphasis on the familial form
55. Amyloid and amyloidosis of the skin
56. Skin involvement in generalized amyloidosis: a study of clinically involved and uninvolved skin in 50 patients with primary and secondary amyloidosis
57. Systemic amyloidosis and the skin: a review with special emphasis on clinical features and therapy
58. Amyloidosis (AL): clinical and laboratory features in 229 cases
59. Primary amyloidosis. Clinical, immunochemical and immunoglobulin metabolism studies in fifteen patients
60. Targetlike skin lesions in primary amyloidosis
61. Amyloid vascular disease: cord-like thickening of mucocutaneous arteries, intermittent claudication and angina in a case with underlying myelomatosis
62. Amyloidosis palpebrarum
63. Xanthoma-like skin lesions as a presenting feature in primary systemic amyloidosis
64. A clinical analysis of the course and prognosis of forty-two patients with amyloidosis
65. Primary systemic amyloidosis presenting as scleroderma
66. Alopecia universalis. A manifestation of occult amyloidosis and multiple myeloma
67. Bullous amyloidosis
68. Bullous lesions of the skin and mucous membranes in primary amyloidosis
69. Primary systemic amyloidosis imitating porphyria cutanea tarda
70. Systemic amyloidosis with an underlying lymphoproliferative disorder. Report of a case in which nail involvement was a presenting feature
71. Amyloid elastosis: a new cutaneous and systemic pattern of amyloidosis
72. Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy
73. Cutis laxa associated with amyloidosis
74. Amyloid lymphadenopathy
75. Sicca syndrome due to primary amyloidosis
76. The shoulder-pad sign—a diagnostic feature of amyloid arthropathy
77. Nodular cutaneous amyloidosis involving the vulva. Case report and literature review
78. Interscapular cutaneous amyloidosis
79. Macular amyloidosis
80. Lichen amyloidosis. Clinical study of 40 cases
81. Lichen amyloidosus. A relatively common skin disorder in Taiwan
82. Biphasic amyloidosis: link between macular and lichenoid forms
83. Diffuse biphasic amyloidosis
84. Diffuse biphasic cutaneous amyloidosis
85. Macular amyloidosus
86. Primary localised macular cutaneous amyloidosis: histochemistry and electron microscopy
87. Primary familial cutaneous amyloidosis: a study of HLA antigens in a Puerto Rican family
88. Localized amyloidosis cutis associated with psoriasis in siblings
89. Amyloidosis cutis. Familial occurrence in three generations
90. Familial lichen amyloidosis. Report of 19 cases in 4 generations of a Chinese family in Malaysia
91. Familial primary cutaneous amyloidosis
92. Macular amyloidosis simulating naevoid hyperpigmentation
93. Macular amyloidosis, presenting as periocular hyperpigmentation
94. Poikiloderma-like cutaneous amyloidosis. Report of a case and review of the literature
95. Coeliac disease with primary cutaneous amyloidosis
96. Diseases of the umbilical, perianal and genital regions: anosacral cutaneous amyloidosis
97. Amyloidosis
98. Amyloidosis of the skin: a comparison between localized and systemic amyloidosis
99. Skin function and amyloidosis
100. Occurrence of amyloid deposits in the skin in secondary systemic amyloidosis
101. Ultrastructure of skin biopsies from patients with heredo-familial amyloid polyneuropathy
102. The nature, pathogenesis and staining properties of amyloid
103. On the binding of Congo red by amyloid
104. Congo red as a stain for fluorescence microscopy of amyloid
105. Lichen amyloidosus. Histochemical and electron microscopic studies
106. An evaluation of current methods for the diagnostic histochemistry of amyloid
107. Lichen amyloidosus. A histochemical and electron microscopic study
108. Fluorescent stains, with special reference to amyloid and connective tissues
109. Fluorescent stain for amyloid. An easy histological differentiation between cutaneous amyloidosis, colloid milium and senile elastosis
110. Fluorescence microscopy with thioflavine-T in the diagnosis of amyloid
111. Amyloid staining with thioflavine T in dermatopathology
112. Staining of amyloid with cotton dyes
113. Fluorescence microscopy of amyloid. Using mixed illumination
114. Potassium permanganate reaction in amyloidosis: a histologic method to assist in differentiating forms of this disease
115. Identification and classification of amyloid in formalin-fixed, paraffin-embedded tissue sections by the unlabelled im munoperoxidase method
116. A new method for the diagnosis of systemic amyloidosis
117. Use of abdominal fat tissue aspirate in the diagnosis of systemic amyloidosis
118. The diagnosis of amyloidosis. Ancillary procedures
119. Gastrointestinal amyloid deposition in AL (primary or myelomaassociated) and AA (secondary) amyloidosis: diagnostic value of gastric biopsy
120. Fine needle aspiration biopsy of the spleen in the diagnosis of systemic amyloidosis
121. Cardiac amyloid deposits in endomyocardial biopsies. Light microscopic, ultrastructural and immunohistochemical studies
122. Imrnunoglobulins and amyloidosis; an immunological study of sixty-two patients with biopsy-proved disease
123. Primary amyloidosis
124. Renal manifestations in multiple myeloma and in primary amyloidosis
125. Primary amyloidosis associated with multiple myeloma. Predictors of successful therapy
126. Clinical and immunochemical studies of 20 patients with amyloidosis and plasma cell dyscrasia
127. Primary systemic amyloidosis. Comparison of melphalan/prednisone versus colchicine
128. Remission in renal amyloidosis
129. Spontaneous remissions of nephrotic syndrome in renal amyloidosis
130. Primary systemic amyloidosis: comparison of melphalan and prednisone versus placebo
131. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever
132. DMSO and colchicine therapy in amyloid disease
133. La régression de l'amylose. Disparition d'une amylose hépatique massive apres nephrectomie pour cancer
134. Renal amyloidosis—a fourteen year follow-up
135. Resolution of renal amyloidosis
136. An apparent cure of secondary amyloidosis due to osteomyelitis
137. Prolonged dimethylsulphoxide treatment in 13 patients with systemic amyloidosis
138. Dimethyl sulfoxide in the treatment of AA amyloidosis
139. Response of systemic amyloidosis to dimethyl sulfoxide
140. Renal amyloidosis: pathogenesis and therapy
141. Continuous ambulatory peritoneal dialysis in systemic amyloidosis and end-stage renal disease
142. Systemic amyloidosis involving two renal transplants
143. Nodular primary localised cutaneous amyloidosis: immunohistochemical evaluation and treatment with the carbon dioxide laser
144. Dermabrasion for lichen amyloidosus. Report of a long-term study
145. Lichen amyloidosus: a new therapeutic approach
146. Dimethyl sulphoxide and macular amyloidosus
147. Treatment of lichen amyloidosus by etretinate
148. Failure of etretinate (Ro 10-9359) in lichen amyloidosus